Article info
PDFORIGINAL ARTICLE
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study
- Address correspondence and reprint requests to: John J. Kavanagh, MD, Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 401, Houston, TX 77030, USA. Email: jkavana{at}mdanderson.org; and Ms Denise Mackey, Gynecologic Oncology Group, Administrative Office, Four Penn Center, 1600 JFK Boulevard, Suite 1020, Philadelphia, PA 19103, USA.
Citation
Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study
Publication history
- First published May 1, 2008.
Online issue publication
March 14, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2007, IGCS and ESGO